PREZISTA

Serial Number 78762650
Registration 3236346
800

Registration Progress

Application Filed
Nov 29, 2005
Under Examination
Approved for Publication
Jan 24, 2007
Published for Opposition
Feb 13, 2007
Registered
May 1, 2007

Trademark Image

PREZISTA

Basic Information

Serial Number
78762650
Registration Number
3236346
Filing Date
November 29, 2005
Registration Date
May 1, 2007
Published for Opposition
February 13, 2007
Renewal Date
May 1, 2017
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 27, 2016
Registration
Registered
Classes
005

Rights Holder

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

79
Address
BARNAHELY
RINGASKIDDY, CO. CORK
IE

Ownership History

Tibotec Pharmaceuticals Ltd.

Original Applicant
03
County Cork IE

Tibotec Pharmaceuticals Ltd.

Owner at Publication
03
County Cork IE

Tibotec Pharmaceuticals Ltd.

Original Registrant
03
County Cork IE

TIBOTECH PHARMACEUTICALS

New Owner After Registration #1
03
LITTLE ISLAND, COUNTY OF CORK IE

JANSSEN R&D IRELAND

New Owner After Registration #2
03
LITTLE ISLAND CO. CORK IE

JANSSEN SCIENCES IRELAND UC

New Owner After Registration #3
99
LITTLE ISLAND, COUNTY CORK IE

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

New Owner After Registration #4
79
RINGASKIDDY, CO. CORK IE

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
657 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-05-01)
Due Date
May 01, 2027
Grace Period Ends
November 01, 2027

Application History

32 events
Date Code Type Description
Feb 6, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 27, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 27, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 27, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 27, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 8, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED
May 1, 2016 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 21, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 15, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 15, 2013 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 15, 2013 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 4, 2013 E815 I TEAS SECTION 8 & 15 RECEIVED
May 16, 2012 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 12, 2011 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 9, 2010 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2007 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 13, 2007 PUBO A PUBLISHED FOR OPPOSITION
Jan 24, 2007 NPUB O NOTICE OF PUBLICATION
Jan 9, 2007 IUAA P USE AMENDMENT ACCEPTED
Jan 9, 2007 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 3, 2007 ALIE A ASSIGNED TO LIE
Jan 3, 2007 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Jan 3, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED
Nov 27, 2006 MAIL I PAPER RECEIVED
Nov 16, 2006 EAAU I TEAS AMENDMENT OF USE RECEIVED
Nov 16, 2006 IUAF S USE AMENDMENT FILED
Jun 2, 2006 CNRT R NON-FINAL ACTION WRITTEN
Jun 2, 2006 GNRT F NON-FINAL ACTION E-MAILED
May 31, 2006 DOCK D ASSIGNED TO EXAMINER
Dec 5, 2005 NWAP I NEW APPLICATION ENTERED IN TRAM

Detailed Classifications

Class 005
Human pharmaceuticals, namely anti-virals for treatment of HIV
First Use Anywhere: Jun 26, 2006
First Use in Commerce: Jun 26, 2006

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...